Funder: Pershing Square Philanthropies
Due Dates (Anticipated): February 2027: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to 10% indirect costs)
Summary: Supports bold, collaborative research to advance transformative solutions for ovarian cancer.
Key Information: Forecasted opportunity—dates and details may shift; nomination by an Advisory Board member or Prize winner required.